Adalimumab 83012-0045
Product NDC
83012-0045- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- January 13, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Adbm | 50 mg/mL |
Packaging Options(1)
20000 mL in 1 BAG (83012-045-99)